Status: Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors.
Participants needed: 240
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Bristol-Myers SquibbUpdated: Apr 15, 2026Locations: 17
Eligibility criteria
Participants must have an Eastern Cooperative Oncology Group Performance Status... [+2]
Participants must not have Leptomeningeal metastases. [+3]